T1	Participants 83 142	children and adolescents with GH and cortisol insufficiency
T2	Participants 274 333	children and adolescents with GH and/or cortisol deficiency
T3	Participants 354 378	20 patients (2-18 years)
T4	Participants 549 676	Of the 14 patients, seven were ACTH sufficient (PHDC+) and seven ACTH deficient (PHDC-). Six had primary adrenal failure (PAF).
